NEUVÉ Health Tirzepatide Review: $324/Month, and Three Answers on What It Buys (2026)

NEUVÉ Health prices the standard weekly tirzepatide injection with B12 at $324 a month, month to month, on a public page that asks for neither an account nor an intake. That is the standard dose rather than the cheaper microdose tier: a microdose is not a therapeutic dose, and we do not headline one. Every figure below was read on 1 September 2026.¹

The whole ladder is published, and that is unusual

The rest of the range sits beside it: the injectable microdose at $240, the daily sublingual microdose at $160 and the sublingual full dose at $282. The GLP-1 lab panel the site marks as required is priced at $45, once. That much visible before anyone asks for an email address is a real strength.

Three answers to one question about the same price

Whether the medication is inside those figures is answered three ways on three of NEUVÉ's own pages. The weight-loss program page carries the heading All-in monthly pricing. and directly beneath it, the line that medication, labs and supplies are billed separately by an independent clinical partner. The pricing page says the monthly figure covers the clinician consultation, protocol design, dose adjustments and follow-up. The Financial Policy goes further and puts the consultation outside the fee too, leaving membership and coaching as the only things NEUVÉ bills you for. Until that is settled, $324 cannot be set against an all-in price elsewhere, so we publish it with its qualifier attached.

Four floors, a password, and legal pages that call themselves drafts

Four different from floors are advertised, and the lowest, $127 a month, is a testosterone price rather than a GLP-1 one. The $160 tirzepatide sublingual microdose card lists compounded sublingual semaglutide in its own inclusion list. The personalized plan that August visitors saw before creating an account now sits behind a password. And every legal page — Terms, Privacy, Refund and Financial Policy — closes by calling itself summary copy under review by counsel and liable to change before public launch, on a live site taking intake.

The brand-vs-compounded question

This is compounded tirzepatide, prepared by a pharmacy rather than manufactured by Lilly, so it is not an FDA-approved finished product. If the cheaper tiers drew you here, read our guide to tirzepatide microdosing before treating $160 as a substitute for $324.

How the care model holds up

In its favor: NEUVÉ names an operating entity in Neuve Health, LLC of Gilbert, Arizona, states Arizona law, says its compounding runs through a 503A pharmacy, and refunds the current month if a clinician declines to treat you. Against it: the pharmacy is not named, the independent clinical partner that bills for the drug is not named in any policy, and no prescribing physician appears; a census of its pages returned no NPI, and no phone number is published anywhere.

Does the drug work? (Separate from the provider)

What a seller charges and what a molecule does are separate questions. SURMOUNT-1 put weight loss at roughly 15% to 21% of body weight over 72 weeks², and a head-to-head trial placed it ahead of semaglutide³. Both studied the branded product at approved doses rather than a compounded copy, and neither studied a microdose; our tirzepatide evidence guide has the rest.

The honest verdict

NEUVÉ publishes an unusually complete price list and an unusually thin account of its supply chain, and the two cancel out. A figure you can read in ten seconds is worth little while the site disagrees with itself about what it includes. Nex Gen Health Rx charges $239 per 30 days and names the pharmacy that dispenses it, so what the money buys is not in dispute there. Oria Meds is the mirror image at $369 a month — a named pharmacy with a street address, but a public site that never names the molecule. The ranked field is in our best tirzepatide providers list.